# Skin & Aesthetics Peptide FAQ — GHK-Cu and GLOW — Luxury Peptides

> Frequently asked questions about GHK-Cu and the GLOW research blend — answered from the peer-reviewed literature, with citations. Covers mechanism, evidence, regulatory status, and the difference between GHK and GHK-Cu.

Plain, citation-anchored answers to the questions readers most often bring to copper-peptide and aesthetic-blend research.

## What does a GHK-Cu peptide do?

GHK-Cu does two things at once: it acts as a copper chaperone (ferrying copper to where enzymes need it) and as a signaling molecule that tells skin and connective-tissue cells to rebuild their scaffolding. At picomolar-to-nanomolar concentrations it directly stimulates dermal fibroblasts to produce collagen, elastin, glycosaminoglycans, and the proteoglycan decorin, while rebalancing the enzymes that break those structures down [4][6]. At the gene level, a Connectivity Map analysis reported a broad transcriptomic shift in roughly 31.2% of human genes toward repair, DNA-fidelity, and antioxidant programs [2]. Most of its documented human benefit is from topical application to skin.

## What is GHK-Cu and how does it work?

GHK-Cu is the Glycyl-L-Histidyl-L-Lysine Copper(II) complex — a three-amino-acid peptide (glycine, histidine, lysine) bound tightly to a copper ion. The same GHK sequence occurs naturally inside type I collagen, your skin's main structural protein. When liberated from collagen during tissue remodeling it appears to act as a local repair signal, and the copper-bound form is what carries most of its documented activity [4][7]. It is also called copper tripeptide-1 in cosmetic labeling. At the mechanism level it tells fibroblasts to make more collagen and elastin, activates antioxidant defenses, and promotes formation of new blood vessels, while suppressing inflammatory signals including TGF-beta-1 and TNF-alpha [6].

## Is GHK-Cu peptide really anti-aging?

There is modest, real, but mostly topical and small-scale human evidence for skin benefits. Topical GHK-Cu increased collagen production in about 70% of treated subjects versus 50% for vitamin C and 40% for retinoic acid, and placebo-controlled studies document improvements in skin laxity, fine lines, and wrinkle depth and density [1][4]. Two honest caveats: the widely cited "~4,000 genes" figure is a broad-threshold extrapolation from a verified figure of roughly 2,100 genes at the 50%-or-greater threshold [2], and GHK-Cu penetrates intact skin poorly, limiting how much reaches the dermis without delivery aids like microneedling or palmitoylation [1]. Sweeping systemic anti-aging claims go beyond what the controlled trial record supports.

## What is the difference between GHK and GHK-Cu?

GHK is the bare tripeptide glycyl-histidyl-lysine; GHK-Cu is that same tripeptide chelated to a copper(II) ion. The difference is biologically important — copper coordination is required for most of GHK's reported bioactivities, including the matrix-metalloproteinase-2 stimulation and collagen cross-linking activity. The free GHK tripeptide does not reproduce those effects in cell studies [4]. In practice, when research describes collagen stimulation, elastin synthesis, and the antioxidant and gene-expression effects, it is the copper complex doing the work. The two are frequently conflated in secondary sources, so checking whether a given study used the copper-bound form matters.

## What is GLOW peptide?

GLOW is a co-formulated research blend of three distinct peptides — GHK-Cu, BPC-157, and TB-500 — combined because their mechanisms are thought to be complementary: matrix-building (GHK-Cu), pro-angiogenic vascular repair (BPC-157), and cell-migration support (TB-500) [8]. It is not a single molecule, not an approved drug, and not standardized across suppliers — ratios and purity vary. GLOW is distinct from the KLOW and WOLVERINE blends, which have different constituent peptides. The closest peer-reviewed reference to the specific three-peptide combination is a 2026 Sports Medicine review that names all three constituents among unapproved research peptides for musculoskeletal conditions [8].

## What does the GLOW peptide do?

According to single-constituent research: the GHK-Cu arm is studied for skin matrix regeneration and collagen/elastin synthesis [4][6]; the BPC-157 arm is studied for pro-angiogenic repair — it activates the VEGFR2-Akt-eNOS vessel-growth pathway in endothelial cells and animal models [10]; and the TB-500 arm is studied for actin-regulated cell migration and reduced scarring, though most of the relevant efficacy data use full-length thymosin beta-4 rather than the short TB-500 fragment [8]. What GLOW as a blend does in a human trial is unknown — no such trial has been published [8][9].

## What does GLOW peptide have in it?

Typically three peptides: (1) GHK-Cu — a copper-carrying tripeptide, the matrix-building and skin-renewal component; (2) BPC-157 — a synthetic fifteen-amino-acid peptide derived from a gastric body-protection protein, the cytoprotective and pro-angiogenic component; and (3) TB-500 — a seven-amino-acid acetylated fragment (Ac-LKKTETQ) corresponding to the actin-binding region of thymosin beta-4, the cell-migration and anti-scarring component [8]. Exact ratios are supplier-specific and not standardized. GLOW is not a single approved ingredient — it is a combination of research chemicals, and two of its three constituents (BPC-157 and TB-500) are prohibited in sport by WADA [8].

## What peptides are in the GLOW blend?

GHK-Cu, BPC-157, and TB-500 are the three standard constituents of the GLOW blend. GHK-Cu is the copper-bound form of the tripeptide glycyl-L-histidyl-L-lysine, also known as copper tripeptide-1. BPC-157 is a stable synthetic pentadecapeptide with the sequence GEPPPGKPADDAGLV. TB-500 is the short heptapeptide Ac-LKKTETQ, the actin-binding region of thymosin beta-4. A 2026 Sports Medicine review that mentions all three together characterizes each as part of an unapproved-peptide landscape with promising animal data but scarce rigorous human safety evidence and potential for harm [8]. These three peptides are distinct from any brand-named pharmaceuticals — no trade names are used on this desk.

## Is GHK-Cu a legal ingredient?

As a topical cosmetic ingredient, yes — copper tripeptide-1 is a legal, widely marketed cosmetic ingredient in the US, EU, and UK with a long safety record in skincare products. As an injectable or orally consumed compound for any medical purpose, no — there is no FDA- or EMA-approved GHK-Cu pharmaceutical product by any systemic route, and such use is unapproved and research-only [1]. The legal status is route-dependent: topical cosmetic is fine; non-topical is research chemical territory.

## Can athletes use GHK-Cu or GLOW?

GHK-Cu as a topical cosmetic is not currently listed on the WADA Prohibited List, though WADA's catch-all S0 category (non-approved pharmacological substances) can in principle cover any non-approved agent — athletes should verify the current list before any research context [1]. GLOW, however, is off-limits for tested athletes because two of its three components are WADA-prohibited: TB-500 (thymosin beta-4 fragment) is banned under class S2 (peptide hormones, growth factors and mimetics) at all times, and BPC-157 is banned under S0 [8]. There is no exemption for intent or skin-focused application — the WADA prohibition follows the compound.

## What are the side effects of copper peptides like GHK-Cu?

The most commonly reported adverse experiences from topical copper peptide use are skin irritation, redness, itching, or dryness — particularly on sensitive skin or when starting at high concentration. Some users report a breakout phase and a small number describe a "dullness" effect where skin looks worse rather than better, called the "copper uglies" in skincare communities. Topical copper peptides can also react badly with vitamin C, strong acids (AHAs/BHAs), and retinol, appearing to stop working or causing added irritation — a formulation-stability issue linked to disruption of the copper-peptide complex [1]. For injectable research use, injection-site redness, stinging, and occasional flushing or metallic taste are reported anecdotally. None of these are documented clinical adverse events from controlled trials; they are community-reported experiences, not clinical safety findings.

## Does GHK-Cu help with hair loss?

There is one controlled human trial: a 6-month placebo-controlled study in 45 men with androgenetic alopecia found that a complex of 5-aminolevulinic acid plus the glycyl-histidyl-lysine peptide (the GHK sequence, applied topically with a delivery aid) increased hair count significantly versus placebo, with the larger of two tested concentrations producing an increase of 71.5 versus only 9.6 for placebo (p<0.05), and no adverse events in any group [3]. It is a combination product — not pure GHK-Cu — so the contribution of each component cannot be isolated from that study alone. Mechanistically, GHK-Cu has been noted for activity at hair follicle dermal papilla cells and for anti-apoptotic effects [4]. More research, especially studies using pure GHK-Cu, would be needed to establish the effect more firmly.

---

A literature digest — what the published science says about copper-peptide and aesthetic-blend research, not what to buy or do.